A registration statement on Form S-1 (File No. 333-284225) relating to the offering has been filed with the Securities and Exchange Commission and became effective on January 30, 2025. The offering is ...

When available, copies of the final prospectus relating to the initial public offering may be obtained from: BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255 ...

Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common ...

SailPoint Inc., an enterprise security software company owned by Thoma Bravo, and shareholders are seeking to raise as much ...

Sailpoint said Thoma Bravo, which took the company private in 2022 in a deal valued at about $6.9 billion, plans to sell 2.5 million shares in the IPO, bringing the size of the offering to 50 million ...

In addition, Maze Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,312,500 shares of common stock at the initial public offering price, less underwriting ...

The concurrent private placement of 1,000,000 shares to an existing investor at the initial public offering price adds an additional $17 million to Beta Bionics’ capital raise, further boosting ...

today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. The gross proceeds to Beta Bionics from the ...

For more information, please visit ipo.derayah.com ...

Smithfield will not receive any proceeds from the sale of the shares by the selling shareholder. Acting joint lead ...

today announced the closing of its initial public offering (the "Offering") of 1,750,000 ordinary shares at a public offering price of $4 per share. The ordinary shares began trading on Nasdaq ...